Response to: “Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test”

Title
Response to: “Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test”
Authors
Keywords
-
Journal
EBioMedicine
Volume 62, Issue -, Pages 103139
Publisher
Elsevier BV
Online
2020-11-27
DOI
10.1016/j.ebiom.2020.103139

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now